Long acting beta 2 agonists and the risk of life threatening asthma (editorial; comment)

Ernst P

首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Long acting beta 2 agonists and the risk of life threatening asthma (editorial; comment)

【24h】

Long acting beta 2 agonists and the risk of life threatening asthma (editorial; comment)

机译：长效β2激动剂和威胁生命的哮喘的风险（编辑;评论）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thorax: The Journal of the British Thoracic Society》 |1998年第1期|共2页
作者
Ernst P;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;外科学各论;
关键词
Adrenergic beta-Agonists; Albuterol; Asthma; Fenoterol; salmeterol; 肾上腺素能β激动剂; 沙丁胺醇; 哮喘;

机译：Adrenergic beta-Agonists;Albuterol;Asthma;Fenoterol;salmeterol;肾上腺素能β激动剂;沙丁胺醇;哮喘;

相似文献

外文文献
中文文献
专利

1. Long acting beta 2 agonists and the risk of life threatening asthma (editorial; comment) [J] . Ernst P Thorax: The Journal of the British Thoracic Society . 1998,第1期

机译：长效β2激动剂和威胁生命的哮喘的风险（编辑;评论）
2. ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO INHALED CORTICOSTEROIDS +/- LONG-ACTING beta(2)-AGONISTS IMPROVES LUNG FUNCTION AND ASTHMA CONTROL AND REDUCES RISK OF ASTHMA WORSENING IN PATIENTS WITH MODERATE OR SEVERE ASTHMA. [J] . Murphy K., Bensch G., Berger W. E., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：对吸入的皮质类固醇激素+/-长期服用β（2）激动剂的一次补全性噻托溴铵（R）可改善肺功能和哮喘控制，并减轻中度或重度哮喘患者的哮喘恶化风险。
3. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination. [J] . Angus R, Reagon R, Cheesbrough A International journal of clinical practice . 2005,第2期

机译：在哮喘患者中，短效β2受体激动剂和口服皮质类固醇激素的使用是同时使用倍氯米松和长效β2受体激动剂或沙美特罗/丙酸氟替卡松联合使用。
4. Positioning of Inhaled Corticosteroids/Long Acting P Agonists in the Japanese Asthma Management Guideline [C] . T. Nakagawa, Y. Komase Asia Pacific Congress of Allergology and Clinical Immunology . 2004

机译：在日本哮喘管理指南中定位吸入的皮质类固醇/长效P激动剂
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Long acting beta 2 agonists and the risk of life threatening asthma [O] . P. Ernst 1998

机译：长效β2激动剂和威胁生命的哮喘风险
7. Long acting beta 2 agonists and the risk of life threatening asthma [O] . Ernst, P. 1998

机译：长效β2激动剂和威胁生命的哮喘风险

Long acting beta 2 agonists and the risk of life threatening asthma (editorial; comment)

著录项

相似文献

相关主题

期刊订阅